Haruhiko Fukuda

16.3k total citations · 6 hit papers
225 papers, 10.0k citations indexed

About

Haruhiko Fukuda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Haruhiko Fukuda has authored 225 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pulmonary and Respiratory Medicine, 105 papers in Oncology and 90 papers in Surgery. Recurrent topics in Haruhiko Fukuda's work include Gastric Cancer Management and Outcomes (77 papers), Colorectal Cancer Treatments and Studies (39 papers) and Esophageal Cancer Research and Treatment (38 papers). Haruhiko Fukuda is often cited by papers focused on Gastric Cancer Management and Outcomes (77 papers), Colorectal Cancer Treatments and Studies (39 papers) and Esophageal Cancer Research and Treatment (38 papers). Haruhiko Fukuda collaborates with scholars based in Japan, United States and United Kingdom. Haruhiko Fukuda's co-authors include Kenichi Nakamura, Narikazu Boku, Taro Shibata, Nobutoshi Ando, Masayuki Shinoda, Junki Mizusawa, Kenji Suzuki, Atsushi Ohtsu, Hiroyasu Igaki and Mitsuru Sasako and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Haruhiko Fukuda

210 papers receiving 9.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

2011 1.1k citations Nobutoshi Ando, Hoichi Kato et al. profile →
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

2022 764 citations Masahiro Tsuboi, Keiju Aokage et al. profile →
Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria

2015 603 citations Hiroshi Katayama, Yukinori Kurokawa et al. profile →
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204

2003 546 citations Nobutoshi Ando, Masayuki Shinoda et al. Journal of Clinical Oncology profile →
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

2009 472 citations Narikazu Boku, Haruhiko Fukuda et al. profile →
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

2011 464 citations Masahiro Tsuboi, Taro Shibata et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haruhiko Fukuda Japan	40	6.9k	4.5k	3.4k	941	905	225	10.0k
Taro Shibata Japan	32	2.4k 0.4×	710 0.2×	1.9k 0.6×	71 0.1×	756 0.8×	150	4.8k
Matthew J. Weiss United States	53	3.3k 0.5×	4.6k 1.0×	6.9k 2.0×	175 0.2×	575 0.6×	312	9.8k
Kim R. Geisinger United States	50	2.6k 0.4×	3.5k 0.8×	2.0k 0.6×	304 0.3×	784 0.9×	239	7.9k
David A. Kooby United States	56	3.6k 0.5×	5.1k 1.1×	5.8k 1.7×	747 0.8×	419 0.5×	310	10.5k
Roderich E. Schwarz United States	42	2.4k 0.3×	2.0k 0.4×	2.2k 0.6×	573 0.6×	205 0.2×	184	5.7k
A. Norman United Kingdom	58	5.9k 0.9×	5.2k 1.2×	5.9k 1.7×	1.0k 1.1×	1.6k 1.8×	138	12.3k
Gilles Mentha Switzerland	55	2.5k 0.4×	6.0k 1.3×	4.5k 1.3×	138 0.1×	654 0.7×	253	12.0k
Michael I. D’Angelica United States	56	4.3k 0.6×	6.9k 1.5×	6.2k 1.8×	122 0.1×	599 0.7×	203	10.7k
Yong Chan Ahn South Korea	40	3.3k 0.5×	1.8k 0.4×	2.9k 0.9×	400 0.4×	1.1k 1.2×	282	6.9k
Frederick L. Greene United States	20	2.2k 0.3×	2.5k 0.6×	3.8k 1.1×	226 0.2×	730 0.8×	43	6.8k

Countries citing papers authored by Haruhiko Fukuda

Since Specialization

Citations

This map shows the geographic impact of Haruhiko Fukuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Fukuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Fukuda more than expected).

Fields of papers citing papers by Haruhiko Fukuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhiko Fukuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Fukuda. The network helps show where Haruhiko Fukuda may publish in the future.

Co-authorship network of co-authors of Haruhiko Fukuda

This figure shows the co-authorship network connecting the top 25 collaborators of Haruhiko Fukuda. A scholar is included among the top collaborators of Haruhiko Fukuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruhiko Fukuda. Haruhiko Fukuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kita, Ryosuke, Kei Ito, Ryunosuke Machida, et al.. (2024). Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study). Japanese Journal of Clinical Oncology. 55(2). 189–193. 2 indexed citations

Kita, Ryosuke, Kazuyuki Shimada, Keita Sasaki, et al.. (2024). Multicenter randomized phase III study of high-dose therapy with autologous stem cell transplantation versus observation for patients with newly diagnosed peripheral T-cell lymphoma who achieved complete metabolic response after induction therapy (JCOG2210, TRANSFER study). Japanese Journal of Clinical Oncology. 55(2). 183–188. 2 indexed citations

Fukushima, Takuya, Kunihiro Tsukasaki, Ryunosuke Machida, et al.. (2024). Upfront allo-HSCT after intensive chemotherapy for untreated aggressive ATL: JCOG0907, a single-arm, phase 3 trial.. Journal of Clinical Oncology. 42(16_suppl). 7001–7001. 1 indexed citations

Sekino, Yuta, Yukihiko Sonoda, Ichiyo Shibahara, et al.. (2024). Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO). Japanese Journal of Clinical Oncology. 55(1). 75–79.

Komori, Koji, Yasumasa Takii, Junki Mizusawa, et al.. (2024). Long-term follow-up of the conventional versus no-touch isolation technique for resection of primary colon cancer (JCOG1006): randomized clinical trial. BJS Open. 8(6).

Sugita, Shintaro, Kazuhiro Tanaka, Yoshinao Oda, et al.. (2024). Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306. Japanese Journal of Clinical Oncology. 54(6). 675–680. 1 indexed citations

Tane, Kenta, Satoshi Shiono, Masashi Wakabayashi, et al.. (2024). A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX). Japanese Journal of Clinical Oncology. 54(8). 926–929. 1 indexed citations

Sekino, Yuta, Tomoyuki Hishida, Hiroshige Yoshioka, et al.. (2024). Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG). Japanese Journal of Clinical Oncology. 55(2). 176–182.

Hashimoto, Tadayoshi, Satoshi Maruyama, Yasumasa Takii, et al.. (2023). A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006. Future Oncology. 19(28). 1897–1904.

10.

Aokage, Keiju, Masahiro Tsuboi, Yoshitaka Zenke, et al.. (2022). Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer. Japanese Journal of Clinical Oncology. 52(4). 383–387. 5 indexed citations

11.

Kanemitsu, Yukihide, Kohei Shitara, Junki Mizusawa, et al.. (2021). Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial. Journal of Clinical Oncology. 39(10). 1098–1107. 115 indexed citations

12.

Shimoyama, Ryo, Susumu Hijioka, Nobumasa Mizuno, et al.. (2020). Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study). Pancreatology. 20(6). 1183–1188. 7 indexed citations

13.

Hironaka, Shuichi, Azusa Komori, Ryunosuke Machida, et al.. (2020). The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909. Esophagus. 17(4). 417–424. 8 indexed citations

14.

Miyamoto, Ken‐ichi, Atsuo Takashima, Junki Mizusawa, et al.. (2019). Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial). Japanese Journal of Clinical Oncology. 49(10). 985–990. 6 indexed citations

15.

Okuno, Tatsuya, Masashi Wakabayashi, Ken Kato, et al.. (2017). Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303). International Journal of Clinical Oncology. 22(6). 1042–1049. 31 indexed citations

16.

Shimada, Yasuhiro, Tetsuya Hamaguchi, Junki Mizusawa, et al.. (2014). Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205. European Journal of Cancer. 50(13). 2231–2240. 90 indexed citations

17.

Kurokawa, Yukinori, Manabu Muto, Keiko Minashi, Narikazu Boku, & Haruhiko Fukuda. (2009). A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508. Japanese Journal of Clinical Oncology. 39(10). 686–689. 45 indexed citations

18.

Tobinai, Kensei, Kunihiko Takeyama, Keiko Aikawa, et al.. (2007). Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004. Cancer Science. 98(9). 1350–1357. 8 indexed citations

19.

Itoh, Kuniaki, T. Ohtsu, Haruhiko Fukuda, et al.. (2002). Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505. Annals of Oncology. 13(9). 1347–1355. 44 indexed citations

20.

Fukuda, Haruhiko, Yasuhiro Abe, Tomohiko Matsuzawa, et al.. (1983). Increased Uptake of 2-Deoxy-2-Fluoro(18F)-D-Glucose in Malignant Tumors. 1983(1983). 251–253. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact